Shire Sues Anchen Over Generic Intuniv
Shire PLC has filed suit against Anchen Pharmaceuticals Inc., continuing its crusade to block generic versions of attention deficit hyperactivity disorder treatment Intuniv from entering the market prior to the expiration...To view the full article, register now.
Already a subscriber? Click here to view full article